Why the study?
To explore whether AF-associated SNPs selected from an external large cohort GWAS have predictive power for AF in a Korean population using a convolutional neural network.
Does a convolutional neural network using GWAS SNPs predict atrial fibrillation in a Korean population?
Does a convolutional neural network using GWAS SNPs predict atrial fibrillation in a Korean population?
A convolutional neural network using GWAS SNPs can predict atrial fibrillation with moderate accuracy based on genetic information alone, demonstrating the utility of AI in capturing polygenic effects.
Answers are grounded in this paper and cite their sources.
Non-significant SNPs yield no AF prediction via CNN-GWAS; leaves open whether AI polygenic models aid risk stratification in East Asians.
OBJECTIVE: We previously reported early-onset atrial fibrillation (AF) associated genetic loci among a Korean population. We explored whether the AF-associated single-nucleotide polymorphisms (SNPs) selected from the Genome-Wide Association Study (GWAS) of an external large cohort has a prediction power for AF in Korean population through a convolutional neural network (CNN). METHODS: This study included 6358 subjects (872 cases, 5486 controls) from the Korean population GWAS data. We extracted the lists of SNPs at each p value threshold of the association statistics from three different previously reported ethnical-specific GWASs. The Korean GWAS data were divided into training (64%), validation (16%) and test (20%) sets, and a stratified K-fold cross-validation was performed and repeated five times after data shuffling. RESULTS: obtained the highest saliency score. The CNN-GWAS did not show AF prediction power by SNPs with non-significant p value subset (AUC 0.56±0.01) despite larger numbers of SNPs. The CNN-GWAS had no prediction power for odd-even registration numbers (AUC 0.51±0.01). CONCLUSIONS: AF can be predicted by genetic information alone with moderate accuracy. The CNN-GWAS can be a robust and useful tool for detecting polygenic diseases by capturing the cumulative effects and genetic interactions of moderately associated but statistically significant SNPs. TRIAL REGISTRATION NUMBER: NCT02138695.
No takes yet. Share an insight, caveat, or question.
Kwon et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: